Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-09-23 4:11 pm Purchase | 2022-09-14 | 13G | Edgewise Therapeutics, Inc. EWTX | Deep Track Capital, LP | 3,374,394 5.340% | 3,374,394 (New Position) | Filing History |
| 2022-09-19 4:07 pm Purchase | 2022-09-16 | 13G | Syros Pharmaceuticals, Inc. SYRS | Deep Track Capital, LP | 699,281 9.990% | 699,281 (New Position) | Filing History |
| 2022-09-16 4:08 pm Purchase | 2022-09-06 | 13G | IVERIC bio, Inc. ISEE | Deep Track Capital, LP | 9,000,000 7.620% | 9,000,000 (New Position) | Filing History |
| 2022-09-12 4:19 pm Purchase | 2022-09-02 | 13G | Ardelyx, Inc. ARDX | Deep Track Capital, LP | 14,252,831 8.450% | 14,252,831 (New Position) | Filing History |
| 2022-08-22 4:16 pm Purchase | 2022-08-12 | 13G | Vigil Neuroscience, Inc. VIGL | Deep Track Capital, LP | 3,684,619 9.990% | 3,684,619 (New Position) | Filing History |
| 2022-08-22 4:13 pm Purchase | 2022-08-12 | 13G | Silence Therapeutics plc SLN | Deep Track Capital, LP | 5,854,740 5.440% | 5,854,740 (New Position) | Filing History |
| 2022-08-19 4:03 pm Purchase | 2022-08-09 | 13G | Heron Therapeutics, Inc. HRTX | Deep Track Capital, LP | 12,232,267 9.990% | 12,232,267 (New Position) | Filing History |
| 2022-07-07 09:24 am Purchase | 2022-06-29 | 13G | 89bio, Inc. ETNB | Deep Track Capital, LP | 4,331,499 9.990% | 4,331,499 (New Position) | Filing History |
| 2022-06-23 4:01 pm Purchase | 2022-06-13 | 13G | Nuvation Bio Inc. NUVB | Deep Track Capital, LP | 11,471,281 5.260% | 11,471,281 (New Position) | Filing History |
| 2022-06-17 4:04 pm Purchase | 2022-06-10 | 13G | Global Blood Therapeutics, Inc. GBT | Deep Track Capital, LP | 3,646,690 5.600% | 3,646,690 (New Position) | Filing History |
| 2022-06-10 4:02 pm Purchase | 2022-06-01 | 13G | Nurix Therapeutics, Inc. NRIX | Deep Track Capital, LP | 2,436,164 5.190% | 2,436,164 (New Position) | Filing History |
| 2022-06-03 4:12 pm Purchase | 2022-05-26 | 13G | Forma Therapeutics Holdings, Inc. FMTX | Deep Track Capital, LP | 2,686,655 5.620% | 2,686,655 (New Position) | Filing History |
| 2022-05-19 4:10 pm Purchase | 2022-05-09 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | Deep Track Capital, LP | 917,825 5.370% | 917,825 (New Position) | Filing History |
| 2022-05-16 4:55 pm Purchase | 2022-05-06 | 13G | Travere Therapeutics, Inc. TVTX | Deep Track Capital, LP | 3,435,200 5.410% | 985,200 (+40.21%) | Filing History |
| 2022-04-18 4:15 pm Purchase | 2022-04-14 | 13G | Inozyme Pharma, Inc. INZY | Deep Track Capital, LP | 3,250,000 8.110% | 3,250,000 (New Position) | Filing History |
| 2022-04-08 4:34 pm Purchase | 2022-03-31 | 13G | Agenus Inc. AGEN | Deep Track Capital, LP | 775,927 5.920% | 775,927 (New Position) | Filing History |
| 2022-03-04 4:10 pm Purchase | 2022-03-02 | 13G | HOOKIPA Pharma Inc. HOOK | Deep Track Capital, LP | 503,600 9.900% | 503,600 (New Position) | Filing History |
| 2022-02-18 4:11 pm Purchase | 2022-02-17 | 13G | Nkarta, Inc. NKTX | Deep Track Capital, LP | 1,965,684 5.970% | 1,965,684 (New Position) | Filing History |
| 2022-02-16 4:46 pm Purchase | 2022-02-14 | 13G | Chinook Therapeutics, Inc. KDNY | Deep Track Capital, LP | 2,752,070 5.040% | 2,752,070 (New Position) | Filing History |
| 2022-02-14 09:08 am Purchase | 2021-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Deep Track Capital, LP | 1,900,000 4.000% | 1,334 (+0.07%) | Filing History |